Pathogenesis of gut dysfunction in bowel obstruction and after obstruction is resolved
肠梗阻时及梗阻解除后肠道功能障碍的发病机制
基本信息
- 批准号:9334200
- 负责人:
- 金额:$ 34.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-24 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAbdominal PainAcuteAcute AbdomenAdmission activityAdultAfferent NeuronsAmericanBrain-Derived Neurotrophic FactorCationsChildChronicColonCongenital MegacolonConstipationDefecationDevelopmentDinoprostoneDistalFecal IncontinenceFunctional disorderGene ExpressionGenetic TranscriptionGoalsHealthHospital CostsHospitalsHypersensitivityImpairmentInterventionIntestinal ObstructionIntestinesLength of StayMalignant - descriptorMeasuresMechanical StressMechanicsMediator of activation proteinMegacolonModelingMolecularMuscle functionNerveNerve Growth FactorsNeuronal PlasticityNeuronsObstructionOperative Surgical ProceduresOralPTGS2 genePainPathogenesisPatientsPlayPre-Clinical ModelProductionProstaglandinsRattusResolutionRoleSiteSmooth Muscle MyocytesSpinal GangliaSurgeonSymptomsTRPV1 geneTestingTherapeuticTimeUp-RegulationVisceralVoltage-Gated Potassium ChannelWomancell motilityconstrictioncyclooxygenase 2effective therapyfollow-upgastrointestinalgastrointestinal symptomimprovedin vitro Modelin vivoinhibitor/antagonistmouse PGE synthase 1new therapeutic targetnovelnovel strategiespreventprophylacticprotein kinase Dpublic health relevancereceptorresponsevoltage
项目摘要
DESCRIPTION (provided by applicant): Bowel obstruction (BO) is a significant health challenge in adults and children, and accounts for more than 300,000 hospital admissions in the US per year. Abdominal pain and motility dysfunction are two main concerns in the conservative management of BO, especially in inoperable and malignant BO. About 57% of BO patients are treated by surgery. The current surgical approach is to release blockage or remove the distal constrictive segment, but to leave alone the distended segment in the gut. However, after the surgery, many patients suffer long-term gut dysfunction such as abdominal discomfort, pain and constipation. The pathogenesis of gut dysfunction in BO and after its release remains poorly understood. There is no effective treatment for the condition that impacts millions of patients. We hypothesize that mechanical stress-induced gene expression (mechano-transcription) in gut smooth muscle cells (SMC) in the distended segment not only plays a critical role in abdominal pain and motility dysfunction during BO, but exerts prolonged effects on bowel function through its secondary effects on gene expression in colonic sensory neurons and SMC. To test the hypothesis, we will focus on two aspects of gut dysfunction, i.e., abdominal pain in Aim 1 and motility dysfunction in Aim 2. In Aim 1, we propose that mechanical stress-induced expression of pain mediators nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in colonic SMC sensitize colonic sensory neurons and contribute to pain during BO. NGF increases the expression and function of transient receptor potential cation channel subtype V1 (TRPV1) and voltage-gated Na+ channel, whereas BDNF down-regulates the expression and function of voltage-gated K+ channel in colonic sensory neurons. Some of the secondary changes (i.e., up-regulation of TRPV1) in sensory neurons are long-lasting, and account for persistent visceral hypersensitivity after BO is released. In Aim 2, we will investigate the mechanisms of motility dysfunction during BO and after BO is resolved. We found for the first time that protein kinase D (PKD) is profoundly involved in the cellular response to mechanical stress. We will test the working hypothesis that mechano-transcription in colonic SMC plays a critical role in motility dysfunction not only during BO via PKD1-dependent induction of cyclooxygenase-2 (COX-2), but also after BO is resolved through prostaglandin E2 (PGE2)- dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We will use in vivo and in vitro models to define these novel mechanisms. In summary, our study suggests that the once distended oral segment in BO is where mechano-transcription occurs, and is the cause of long-term gut dysfunction. Proposed studies will identify potential prophylactic and therapeutic treatments towards the dysfunction. Inhibition of mechano-transcription during BO (i.e. NGF antiserum and PKD1 inhibitor) may not only improve pain and motility function in BO, but also prevent long-term gut dysfunction, whereas targeting secondary effects (i.e. TRPV1 and mPGES-1) following the release of BO is a potential treatment for long-term gut dysfunction.
DESCRIPTION (provided by applicant): Bowel obstruction (BO) is a significant health challenge in adults and children, and accounts for more than 300,000 hospital admissions in the US per year. Abdominal pain and motility dysfunction are two main concerns in the conservative management of BO, especially in inoperable and malignant BO. About 57% of BO patients are treated by surgery. The current surgical approach is to release blockage or remove the distal constrictive segment, but to leave alone the distended segment in the gut. However, after the surgery, many patients suffer long-term gut dysfunction such as abdominal discomfort, pain and constipation. The pathogenesis of gut dysfunction in BO and after its release remains poorly understood. There is no effective treatment for the condition that impacts millions of patients. We hypothesize that mechanical stress-induced gene expression (mechano-transcription) in gut smooth muscle cells (SMC) in the distended segment not only plays a critical role in abdominal pain and motility dysfunction during BO, but exerts prolonged effects on bowel function through its secondary effects on gene expression in colonic sensory neurons and SMC. To test the hypothesis, we will focus on two aspects of gut dysfunction, i.e., abdominal pain in Aim 1 and motility dysfunction in Aim 2. In Aim 1, we propose that mechanical stress-induced expression of pain mediators nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in colonic SMC sensitize colonic sensory neurons and contribute to pain during BO. NGF increases the expression and function of transient receptor potential cation channel subtype V1 (TRPV1) and voltage-gated Na+ channel, whereas BDNF down-regulates the expression and function of voltage-gated K+ channel in colonic sensory neurons. Some of the secondary changes (i.e., up-regulation of TRPV1) in sensory neurons are long-lasting, and account for persistent visceral hypersensitivity after BO is released. In Aim 2, we will investigate the mechanisms of motility dysfunction during BO and after BO is resolved. We found for the first time that protein kinase D (PKD) is profoundly involved in the cellular response to mechanical stress. We will test the working hypothesis that mechano-transcription in colonic SMC plays a critical role in motility dysfunction not only during BO via PKD1-dependent induction of cyclooxygenase-2 (COX-2), but also after BO is resolved through prostaglandin E2 (PGE2)- dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We will use in vivo and in vitro models to define these novel mechanisms. In summary, our study suggests that the once distended oral segment in BO is where mechano-transcription occurs, and is the cause of long-term gut dysfunction. Proposed studies will identify potential prophylactic and therapeutic treatments towards the dysfunction. Inhibition of mechano-transcription during BO (i.e. NGF antiserum and PKD1 inhibitor) may not only improve pain and motility function in BO, but also prevent long-term gut dysfunction, whereas targeting secondary effects (i.e. TRPV1 and mPGES-1) following the release of BO is a potential treatment for long-term gut dysfunction.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuan-Zheng Peter Shi其他文献
Xuan-Zheng Peter Shi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuan-Zheng Peter Shi', 18)}}的其他基金
Pathogenic Role of Mechanical Stress in Fibrosis and Tissue Remodeling in Crohn's Disease
机械应力在克罗恩病纤维化和组织重塑中的致病作用
- 批准号:
10549370 - 财政年份:2020
- 资助金额:
$ 34.88万 - 项目类别:
Pathogenic Role of Mechanical Stress in Fibrosis and Tissue Remodeling in Crohn's Disease
机械应力在克罗恩病纤维化和组织重塑中的致病作用
- 批准号:
10337289 - 财政年份:2020
- 资助金额:
$ 34.88万 - 项目类别:
Pathogenesis of gut dysfunction in bowel obstruction and after obstruction is resolved
肠梗阻时及梗阻解除后肠道功能障碍的发病机制
- 批准号:
9149191 - 财政年份:2015
- 资助金额:
$ 34.88万 - 项目类别:
Pathogenesis of gut dysfunction in bowel obstruction and after obstruction is resolved
肠梗阻时及梗阻解除后肠道功能障碍的发病机制
- 批准号:
9030244 - 财政年份:2015
- 资助金额:
$ 34.88万 - 项目类别:
INCISIVE OF NUCLEIC ACID CONFORMATIONAL HETEROGENEITY: DNA BULGES
尖锐的核酸构象异质性:DNA 凸出
- 批准号:
8170218 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
PROBING OF NUCLEIC ACID CONFORMATIONAL HETEROGENEITY: STARTING WITH DNA BULGES
核酸构象异质性的探测:从 DNA 凸出开始
- 批准号:
8170235 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
INCISIVE PROBING OF NUCLEIC ACID CONFORMATIONAL HETEROGENEITY: DNA BULGES
深入探究核酸构象异质性:DNA 凸出
- 批准号:
8170223 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Peripheral mechanisms underlying electroacupuncture analgesia in a rat model of c
电针镇痛大鼠模型的外周机制
- 批准号:
7994815 - 财政年份:2009
- 资助金额:
$ 34.88万 - 项目类别:
Obstruction-initiated mechanotranscription in colonic smooth muscle cells
结肠平滑肌细胞中阻塞启动的机械转录
- 批准号:
8293276 - 财政年份:2009
- 资助金额:
$ 34.88万 - 项目类别:
Obstruction-initiated mechanotranscription in colonic smooth muscle cells
结肠平滑肌细胞中阻塞启动的机械转录
- 批准号:
7882330 - 财政年份:2009
- 资助金额:
$ 34.88万 - 项目类别:
相似海外基金
Disrupted sleep architecture in adolescents with functional abdominal pain disorders
患有功能性腹痛疾病的青少年的睡眠结构被破坏
- 批准号:
10641146 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Development and Testing of an Intervention to Facilitate Shared Decision-Making in Pediatric Patients with Abdominal Pain Presenting to the Community Emergency Department Setting
开发和测试一种干预措施,以促进社区急诊科就诊的腹痛儿科患者共同决策
- 批准号:
10723374 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Abdominal Pain in Older Patients in Emergency Departments
急诊科老年患者的腹痛
- 批准号:
10739136 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Evaluation of abdominal pain after mucosal healing in patients with inflammatory bowel disease -comprehensive analysis of HPA axis-
炎症性肠病患者黏膜愈合后腹痛评价-HPA轴综合分析-
- 批准号:
22K16013 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
- 批准号:
10387725 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
- 批准号:
10608073 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Novel microbial driven histamine pathways underlying chronic abdominal pain
慢性腹痛背后的新型微生物驱动组胺途径
- 批准号:
453255 - 财政年份:2021
- 资助金额:
$ 34.88万 - 项目类别:
Operating Grants
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
- 批准号:
10619029 - 财政年份:2020
- 资助金额:
$ 34.88万 - 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
- 批准号:
10045379 - 财政年份:2020
- 资助金额:
$ 34.88万 - 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
- 批准号:
10685484 - 财政年份:2020
- 资助金额:
$ 34.88万 - 项目类别: